Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Published:2013 Issue:1 Volume:8 Page:26
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet Journal of Rare Diseases

Author:

Walter Maggie C,Reilich Peter,Thiele Simone,Schessl Joachim,Schreiber Herbert,Reiners Karlheinz,Kress Wolfram,Müller-Reible Clemens,Vorgerd Matthias,Urban Peter,Schrank Bertold,Deschauer Marcus,Schlotter-Weigel Beate,Kohnen Ralf,Lochmüller Hanns

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Reference22 articles.

2. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

3. Limb-Girdle Muscular Dystrophy in the United States

4. Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype

5. A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy;Skeletal Muscle;2024-08-09

2. Diagnosis of dysferlinopathy masked by a superimposed hypothyroid myopathy;BMJ Case Reports;2024-08

3. The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments;Biomolecules;2024-02-21

4. Patterns of Clinical Progression Among Patients With Autosomal Recessive Limb-Girdle Muscular Dystrophy: A Systematic Review;Journal of Clinical Neuromuscular Disease;2023-12

5. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy;Journal of Neuromuscular Diseases;2023-11-07